Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 26 Pharmaceutical Chemistry (environment) PhD Projects, Programmes & Scholarships

Discipline

Discipline

Chemistry

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Pharmaceutical Chemistry (environment) PhD Projects, Programmes & Scholarships

We have 26 Pharmaceutical Chemistry (environment) PhD Projects, Programmes & Scholarships

Non-thermal plasma as a chemical reagent: elucidating mechanism and exploring NTP for pharmaceutically relevant electroreductive reactions

Chemistry depends on electrons, but we cannot yet fully control electrons to deliver precise reactivity. Controlled high-energy electron sources—such as non-thermal plasma (NTP)—could unlock new and selective chemical transformations, but little is known about these states of matter when mixed with reaction media. Read more

Research Assistant (PhD student)

Profile. MSc-degree or equivalent in subject of Chemistry, Biotechnology, Pharmacy with a strong background in Organic Chemistry or Chemical Biology with synthesis. Read more

Fluorinated tools for chemical biology

A PhD studentship is available in the group of Dr Chris Coxon, School of Chemistry, University of Edinburgh, https://www.chem.ed.ac.uk/staff/academic-staff/dr-christopher-r-coxon. Read more

Pharmacokinetics Guided Natural Products Exploration for Drug Discovery, Development, Delivery and Therapy

  Research Group: Institute of Cancer Therapeutics
Natural products have emerged as a key standard in novel and safe delivery of anticancer bioactive compounds. Apart from their ease of administration and delivery, natural/phytochemicals still face several hurdles, due to their physiochemical and pharmacokinetic properties. Read more

From bench to pre-clinical evaluation: a novel nucleic acid vaccine targeting tumour-associated antigens

Cancer and the long-term toxicities sustained from treatment remain a public health issue for adult and paediatric patients. The spread of tumour cells is believed to account for up to 90% of cancer-related morbidities. Read more

New Drugs for Brain Tumours: Prodrugs of Diazopropyne

  Research Group: Medicines Development and Pharmaceutical Sciences
The propargyl group, introduced to temozolomide-like drugs for brain tumours by our colleagues in Nottingham, shows considerable pre-clinical promise and… Read more

Filtering Results